Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-22T16:50:33.750Z Has data issue: false hasContentIssue false
  • English
  • Français

Monitoring Drugs in Hospitals for the Mentally Handicapped

Published online by Cambridge University Press:  29 January 2018

David H. James
David H. James*
Affiliation:
Purdown Hospital, Stapleton, Bristol BS16 1BG
Get access Rights & Permissions [Opens in a new window]

Summary

The systematic application of guidelines derived from the British National Formulary resulted in a substantial reduction of the amount and frequency of medication used in two hospitals for the mentally handicapped.

Type
Papers
Information
The British Journal of Psychiatry , Volume 142 , Issue 2 , February 1983 , pp. 163 - 165
Copyright
Copyright © 1983 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Breuning, S.E. & Davidson, N. A. (1981) Effects of psychotropic drugs on intelligence test performance of institutionalized mentally retarded adults. American Journal of Mental Deficiency, 85, 575–9.Google ScholarPubMed
Carter, G. P. (1983) Abrupt withdrawal of antiparkinsonian drugs in mentally handicapped patients. British Journal of Psychiatry, 142, 166–8.CrossRefGoogle ScholarPubMed
Fielding, L. T. (1980) An assessment programme to reduce drug use with the mentally retarded. Hospital and Community Psychiatry, 31, 771–3.Google Scholar
Jancar, J. (1970) Gradual withdrawal of tranquillizers with the help of ascorbic acid. British Journal of Psychiatry, 117, 238–9.CrossRefGoogle ScholarPubMed
Kirman, B. (1975) Drug therapy in mental handicap. British Journal of Psychiatry, 127, 545–9.Google Scholar
Lipman, R. S. (1970) The use of psychopharmacological agents in residential facilities for the retarded. in Psychiatric Approaches to Mental Retardation (ed. Menolasino), p. 387–98. New York: Basic Books.Google Scholar
Michel, K. & Kolakowska, T. (1981) A survey of prescribing psychotropic drugs in two psychiatric hospitals. British Journal of Psychiatry, 138, 217–21.Google ScholarPubMed
Schroeder, N. H., Caffey, E. M. & Lorei, T. W. (1977) Antipsychotic drug use. Diseases of the Nervous System, 38, 114–16.Google Scholar
Sewell, J. & Werry, J. S. (1976) Studies in an institution for the mentally retarded. New Zealand Medical Journal, 84, 317–19.Google Scholar
Spencer, D. A. (1974) Survey of medication in a hospital for the mentally handicapped. British Journal of Psychiatry, 124, 507.Google Scholar
Sprague, R. L. (1977) Overview of psychopharmacology for the retarded in the United States. In Research to Practice in Mental Retardation, Volume 3, (ed. P. Mittler) p. 199–202. Baltimore: University Park Press.Google Scholar
Tu, J. & Smith, J. (1979) Factors associated with psychotropic medication in mental retardation facilities. Comprehensive Psychiatry, 20, 289–95.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.